Skip to content

Striae and Phonophoresis

Comparison of topical application of a combination of vitamin C, E and moisturizing ingredients, ultrasound and phonophoresis on the striae distensae in healthy young women

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT201207204203N6
Enrollment
40
Registered
2012-08-04
Start date
2012-09-22
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atrophic disorders of skin. Striae atrophicae

Interventions

Intervention 1: Intervention (3): Just topical application of a combination of vitamin C, E and moisturizing ingredients on striae. This intervention lasts for 30 days/ daily. Intervention 2: Control
Treatment - Drugs
Treatment - Other
Intervention (3): Just topical application of a combination of vitamin C, E and moisturizing ingredients on striae. This intervention lasts for 30 days/ daily.
Control: Placebo ultrasound for 5 minutes. . This intervention lasts for 30 days/ daily.
Intervention (1): using ultrasound 3MHz, pulsative (20%), low intensity 0.8 W/cm2, increasing gradually through sessions, for 5 minutes on abdominal striae . This intervention lasts for 30 days/ daily
Intervention (2): Phonophoresis of a combination of vitamin C, E and moisturizing ingredients using ultrasound 3MHz, pulsative (20%), low intensity 0.8 W/cm2, increasing gradually through sessions, f

Sponsors

Deputy of Research, Semnan University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
17 Years to 35 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: Aged between 17-35years old, striae aged less then 6 months, written consent, sex female. Exclusion criteria: Previous history of disease like cushing syndrome, history of corticosteroid injection, skin disease, abrupt weight gain/loss, presence of any type of medication for striae like drug or cream.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Length of Striae. Timepoint: Before Intervention, following 30 sessions of intervention, 1 month following end of intervention. Method of measurement: through caliper.;Width of Striae. Timepoint: Before Intervention, following 30 sessions of intervention, 1 month following end of intervention. Method of measurement: through caliper.;Intensity of Striae. Timepoint: Before Intervention, following 30 sessions of intervention, 1 month following end of intervention. Method of measurement: Based on computerized software and digitalized photography.;Color of Striae. Timepoint: Before Intervention, following 30 sessions of intervention, 1 month following end of intervention. Method of measurement: Based on computerized software and digitalized photography.;Hue of Striae. Timepoint: Before Intervention, following 30 sessions of intervention, 1 month following end of intervention. Method of measurement: Based on computerized software and digitalized photography.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr. Atefeh Aminian Far

Semnan University of Medical Sciences

aminfar@sem-ums.ac.iraminfar83@yahoo.com+98 23 1335 4182

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026